Synonyms: GB-0139 | GB0139 | TD-139 | TD139
Compound class:
Synthetic organic
Comment: Olitigaltin (GB0139) is a galectin-3 inhibitor [3] that is designed for inhalation, and is intended as a therapy for fibrotic lung conditions such as idiopathic pulmonary fibrosis (IPF) [1]. In the fibrotic setting, blocking galectin-3's biological function is predicted to combat the enhanced TGF-β receptor-mediated macrophage differentiation and myofibroblast activation that drives pathological fibrotic changes [2-4].
|
|
No information available. |
Summary of Clinical Use ![]() |
Olitigaltin (GB0139) has progressed to clinical evaluation to determine its safety and anti-fibrotic efficacy. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT03832946 | A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 Interventional | Galecto Biotech AB |